Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005002 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
BIOLOGICAL: HIV-1 Immunogen
DRUG: Nelfinavir mesylate

Sponsor

Agouron Pharmaceuticals